Calling All Emerging Pharma Leaders!

In this ISSUE

Deeper Dive: Gene Therapy Manufacturing

Paving Bayer’s Future Path

Politics & Pricing to Shape Pharma Prospects in 2020

Pharm Exec's Emerging Pharma Leaders 2020 — Call for Nominations

Join us in celebrating and honoring the up-and-coming leaders that are vital to the future of the pharmaceutical and biotech industry. Nominate a colleague or yourself for Pharm Exec's Emerging Pharma Leaders 2020!
... /Read more/

Break Free from Forecast Inaccuracy: How Machine Learning Can Drive Better Quality Commercial Forecasting
Thursday, February 20, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now

Brexit

Pharma’s Brexit Route

The path for UK life sciences to factor prominently in transition-period maneuvering.
... /Read more/

Market Pricing Dynamics for the Machine Learning Age Are You Getting the Insights You Need?
Thursday, March 26, 2019 at 11am EDT |10am CDT |4pm BST |5pm CEST
Register Now

Executive Profile

Managed Access to Rare Disease Medicines

Natalie Douglas talks about her experience in the area of managed and expanded access and her new venture, RareiTi.
... /Read more/

Calendar

/ Life Sciences Compliance Congress Asia — 2/27-2/28 /

/ 16th Life Sciences Accounting & Reporting Congress — 3/16-3/19 /

/ MASS East Medical Affairs Strategic Summit — 4/14-4/16 /

/ Digital Health for Pharma — 4/20-4/22 /

/ 9th Digital Marketing for Medical Devices West — 4/22-4/24 /

Virtual, Decentralized, Site-less Trials… What Does it All Mean?
Thursday, March 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register Now

The 5 Safes of Risk-Based Anonymization
Wednesday, February 26, 2020 at 10am EST | 9am CST | 3pm GMT | 4pm CET
Register Now

Industry Outlook

Pharm Exec’s 2020 Industry Outlook

Pharm Exec’s annual forecast of the key issues facing biopharma leaders in the year ahead taps experts from several areas to uncover the seven new-decade trends to watch—from finance and policy to talent and technology, and more.
... /Read more/

The Current and Future Impact of Artificial Intelligence (AI) on Pharmacovigilance
Tuesday, February 11, 2020 at 11am EST| 8am PST| 4pm GMT| 5pm CET
Register Now

Regulatory Affairs

FDA: Hahn Era Begins

New FDA commissioner Stephen Hahn announced his priorities at an “all hands” staff meeting last week. Jill Wechsler reports.
... /Read more/

The Pharm Exec Podcast: Episode 49

Navigate Emerging Markets with Data Science

Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health, talk about how they’re using data science in the health and life sciences industries to help clients navigate emerging
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com